|Articles|May 1, 2012 (Updated: November 15, 2020)
- Pharmaceutical Executive-05-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2012
Marooned at the Top
Advertisement
Articles in this issue
almost 14 years ago
Pharma 50 Comment: Seeding Beyond the Basealmost 14 years ago
Value-Based Pricing: Too High a Price for UK Pharma?almost 14 years ago
Pharm Exec 50: Growth from the Bottom Upalmost 14 years ago
Country Report: South Africaalmost 14 years ago
Managing Information Overloadalmost 14 years ago
Super-Size Me: Optimizing the Information Explosionalmost 14 years ago
Government: Big Pharma's Best Friend in Emerging Markets?almost 14 years ago
Information Overloadalmost 14 years ago
Pharma's Winning Innovative TechnologyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
3
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
4
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
5